Thomas Licher
Impact in
- Sensory Systems top 10%
- Ion Channels and Receptors
-
- Amino Acid Enzymes and Metabolism
Papers in
- Oncology 7
- Drug Transport and Resistance Mechanisms 7
-
- Amino Acid Enzymes and Metabolism 2
- Co-authors
- Olaf Pongs (1 shared paper)Patrick Friederich (1 shared paper)Werner Dittrich (1 shared paper)Hartmut Rütten (1 shared paper)Heinz‐Werner Kleemann (1 shared paper)Carsten Strübing (1 shared paper)Thorsten Schmidt (1 shared paper)Matthias Löhn (1 shared paper)
- Journals
- SLAS DISCOVERY (4 papers)Frontiers in Pharmacology (3 papers)ACS Catalysis (1 paper)Advanced Science (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Thomas Licher
16 papers receiving 325 citations
Peers
Comparison fields: 5 of 61
- Sensory Systems 40
- Biochemistry 28
- Oncology 79
- Drug Discovery 1
- Physiology 8
Countries citing papers authored by Thomas Licher
This map shows the geographic impact of Thomas Licher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Licher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Licher more than expected).
Fields of papers citing papers by Thomas Licher
This network shows the impact of papers produced by Thomas Licher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Licher. The network helps show where Thomas Licher may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Licher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 82 | |
| 2 | 2021 | 53 | |
| 3 | 2012 | 44 | |
| 4 | 2003 | 35 | |
| 5 | 2020 | 29 | |
| 6 | 2006 | 15 | |
| 7 | 2004 | 13 | |
| 8 | 2022 | 13 | |
| 9 | 2023 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2013 | 7 | |
| 12 | 2016 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2025 | 2 | |
| 16 | 2024 | 1 |
About Thomas Licher
Thomas Licher is a scholar working on Oncology, Biochemistry, Molecular Biology, Spectroscopy and Sensory Systems, having authored 16 papers that have together received 332 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Ion channel regulation and function (4 papers), Amino Acid Enzymes and Metabolism (2 papers), Ion Transport and Channel Regulation (2 papers), Mass Spectrometry Techniques and Applications (2 papers), Lipid Membrane Structure and Behavior (1 paper), Neuroscience and Neuropharmacology Research (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Sensory Systems (40 citations), Biochemistry (28 citations), Oncology (79 citations), Drug Discovery (1 citation) and Physiology (8 citations). Thomas Licher has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Olaf Pongs, Patrick Friederich, Werner Dittrich, Hartmut Rütten, Heinz‐Werner Kleemann, Carsten Strübing, Thorsten Schmidt, Matthias Löhn, Sven Geibel and Felix Bärenz. Their work appears in journals such as SLAS DISCOVERY, Frontiers in Pharmacology, ACS Catalysis, Advanced Science and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.